Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and Irinotecan in Untreated Extensive Stage SCLC
NCT00030433Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Jan 2002
- Primary completion
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, irinotecan in small cell lung cancer (SCLC), sponsored by SWOG Cancer Research Network. Started Jan 2002; status: completed.
02
Drugs
gemcitabineirinotecan
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00030433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00030433.